Anna Hart
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Anna Hart has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Mark A. Turner
University of Liverpool, Liverpool, UK
2 shared publications - Carol Bedwell
Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, UK
1 shared publication - Colin Morgan
Neonatal Intensive Care Unit, Liverpool Women's Hospital Liverpool UK
1 shared publication - Ediri O'BRien
School of Nursing, Midwifery & Social Work, University of Manchester, Manchester, UK
1 shared publication - Isam Badhawi
Department of Pharmacy, Liverpool Women's Hospital, Crown St, Liverpool L8 7SS, UK
1 shared publication - Kelly Mayes
Dept Clinical Chemistry, Royal Liverpool Children's Hospital, Alder Hey, Liverpool L12 2AP, UK
1 shared publication
Latest Publications
- Open Access
- 3 September 2012
- Published by Wiley in Maternal & Child Nutrition
- Vol. 8 (4) , 421-422
Common statistical mistakes
- 3 September 2012
- Published by Wiley in Maternal & Child Nutrition
- Vol. 8 (4) , 421-422
Open AccessCommon statistical mistakes
- Open Access
- 9 September 2011
- Published by Wiley in Maternal & Child Nutrition
- Vol. 7 (4) , 333-334
The scandal of unpublished research
- 9 September 2011
- Published by Wiley in Maternal & Child Nutrition
- Vol. 7 (4) , 333-334
Open AccessThe scandal of unpublished research
- Open Access
- 10 June 2011
- Published by Springer Nature in BMC Pediatrics
- Vol. 11 (1) , 53
SCAMP: standardised, concentrated, additional macronutrients, parenteral nutrition in very preterm infants: a phase IV randomised, controlled exploratory study of macronutrient intake, growth and other aspects of neonatal care
Infants born <29 weeks gestation are at high risk of neurocognitive disability. Early postnatal growth failure, particularly head growth, is an important and potentially reversible risk factor for impaired neurodevelopmental outcome. Inadequate nutrition is a major factor in this postnatal growth failure, optimal protein and calorie (macronutrient) intakes are rarely achieved, especially in the first week. Infants <29 weeks are dependent on parenteral nutrition for the bulk of their nutrient needs for the first 2-3 weeks of life to allow gut adaptation to milk digestion. The prescription, formulation and administration of neonatal parenteral nutrition is critical to achieving optimal protein and calorie intake but has received little scientific evaluation. Current neonatal parenteral nutrition regimens often rely on individualised prescription to manage the labile, unpredictable biochemical and metabolic control characteristic of the early neonatal period. Individualised prescription frequently fails to translate into optimal macronutrient delivery. We have previously shown that a standardised, concentrated neonatal parenteral nutrition regimen can optimise macronutrient intake.
- 10 June 2011
- Published by Springer Nature in BMC Pediatrics
- Vol. 11 (1) , 53
Open AccessSCAMP: standardised, concentrated, additional macronutrients, parenteral nutrition in very preterm infants: a phase IV randomised, controlled exploratory study of macronutrient intake, growth and other aspects of neonatal care
Infants born <29 weeks gestation are at high risk of neurocognitive disability. Early postnatal growth failure, particularly head growth, is an important and potentially reversible risk factor for impaired neurodevelopmental outcome. Inadequate nutrition is a major factor in this postnatal growth failure, optimal protein and calorie (macronutrient) intakes are rarely achieved, especially in the first week. Infants <29 weeks are dependent on parenteral nutrition for the bulk of their nutrient needs for the first 2-3 weeks of life to allow gut adaptation to milk digestion. The prescription, formulation and administration of neonatal parenteral nutrition is critical to achieving optimal protein and calorie intake but has received little scientific evaluation. Current neonatal parenteral nutrition regimens often rely on individualised prescription to manage the labile, unpredictable biochemical and metabolic control characteristic of the early neonatal period. Individualised prescription frequently fails to translate into optimal macronutrient delivery. We have previously shown that a standardised, concentrated neonatal parenteral nutrition regimen can optimise macronutrient intake.
- Open Access
- 13 May 2011
- Published by Springer Nature in BMC Pediatrics
- Vol. 11 (1) , 35
Infant skin-cleansing product versus water: A pilot randomized, assessor-blinded controlled trial
The vulnerability of newborn babies' skin creates the potential for a number of skin problems. Despite this, there remains a dearth of good quality evidence to inform practice. Published studies comparing water with a skin-cleansing product have not provided adequate data to inform an adequately powered trial. Nor have they distinguished between babies with and without a predisposition to atopic eczema. We conducted a pilot study as a prequel to designing an optimum trial to investigate whether bathing with a specific cleansing product is superior to bathing with water alone. The aims were to produce baseline data which would inform decisions for the main trial design (i.e. population, primary outcome, sample size calculation) and to optimize the robustness of trial processes within the study setting.
- 13 May 2011
- Published by Springer Nature in BMC Pediatrics
- Vol. 11 (1) , 35
Open AccessInfant skin-cleansing product versus water: A pilot randomized, assessor-blinded controlled trial
The vulnerability of newborn babies' skin creates the potential for a number of skin problems. Despite this, there remains a dearth of good quality evidence to inform practice. Published studies comparing water with a skin-cleansing product have not provided adequate data to inform an adequately powered trial. Nor have they distinguished between babies with and without a predisposition to atopic eczema. We conducted a pilot study as a prequel to designing an optimum trial to investigate whether bathing with a specific cleansing product is superior to bathing with water alone. The aims were to produce baseline data which would inform decisions for the main trial design (i.e. population, primary outcome, sample size calculation) and to optimize the robustness of trial processes within the study setting.